These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8461391)

  • 1. Human-murine chimeric CD4 monoclonal antibodies. A modern panacea for autoimmune disease?
    Riethmüller G; Deusch K; Sanders ME; Dalesandro MR; Kiefersauer S; Reiter C; Rieber EP
    Immunol Ser; 1993; 59():261-9. PubMed ID: 8461391
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of autoimmune disease with monoclonal anti-CD4 antibodies.
    Waldor MK
    Immunol Ser; 1989; 45():573-86. PubMed ID: 2577329
    [No Abstract]   [Full Text] [Related]  

  • 3. From treatment of experimental allergic encephalomyelitis to clinical trials in multiple sclerosis.
    Steinman L; Lindsey JW; Alters S; Hodgkinson S
    Immunol Ser; 1993; 59():253-60. PubMed ID: 8461390
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunotherapy of autoimmune disease with anti-T cell antibodies.
    Sriram S
    Concepts Immunopathol; 1989; 7():162-72. PubMed ID: 2676177
    [No Abstract]   [Full Text] [Related]  

  • 5. [Application of chimeric and humanized antibodies to autoimmune diseases therapy].
    Noguchi H
    Nihon Rinsho; 1997 Jun; 55(6):1549-56. PubMed ID: 9200947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal-antibody therapy in systemic vasculitis.
    Mathieson PW; Cobbold SP; Hale G; Clark MR; Oliveira DB; Lockwood CM; Waldmann H
    N Engl J Med; 1990 Jul; 323(4):250-4. PubMed ID: 2366834
    [No Abstract]   [Full Text] [Related]  

  • 7. From antilymphocyte serum to therapeutic monoclonal antibodies: first experiences with a chimeric CD4 antibody in the treatment of autoimmune disease.
    Riethmüller G; Rieber EP; Kiefersauer S; Prinz J; van der Lubbe P; Meiser B; Breedveld F; Eisenburg J; Krüger K; Deusch K
    Immunol Rev; 1992 Oct; 129():81-104. PubMed ID: 1464423
    [No Abstract]   [Full Text] [Related]  

  • 8. Humanization of a mouse antibody against human alpha-4 integrin: a potential therapeutic for the treatment of multiple sclerosis.
    Léger OJ; Yednock TA; Tanner L; Horner HC; Hines DK; Keen S; Saldanha J; Jones ST; Fritz LC; Bendig MM
    Hum Antibodies; 1997; 8(1):3-16. PubMed ID: 9265500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A therapeutic anti-CD4 monoclonal antibody inhibits T cell receptor signal transduction in mouse autoimmune cardiomyopathy.
    Wang ZH; Liao YH; Yuan J; Zhang L; Wang M; Zhang JH; Liu ZP; Dong JH
    Chin Med J (Engl); 2007 Aug; 120(15):1319-25. PubMed ID: 17711737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological activities on T lymphocytes of a baculovirus-expressed chimeric recombinant IgG1 antibody with specificity for the CDR3-like loop on the D1 domain of the CD4 molecule.
    Troadec S; Bès C; Chentouf M; Nguyen B; Briant L; Jacquet C; Chebli K; Pugnière M; Roquet F; Cerutti M; Chardès T
    Clin Immunol; 2006 Apr; 119(1):38-50. PubMed ID: 16426893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies and fusion proteins in medicine.
    Liossis SN; Tsokos GC
    J Allergy Clin Immunol; 2005 Oct; 116(4):721-9; quiz 730. PubMed ID: 16210042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-CD4 monoclonal antibody (mAb) and anti-idiotypic mAb to anti-CD4 in the therapy of autoimmune diseases.
    Perosa F; Scudeletti M; Imro MA; Dammacco F; Luccarelli G; Indiveri F
    Clin Exp Rheumatol; 1997; 15(2):201-10. PubMed ID: 9196876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-gamma interferon (IFN-gamma) monoclonal antibodies.
    Bach JF
    Immunol Ser; 1993; 59():319-28. PubMed ID: 8461396
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-class II antibody treatment in autoimmune diseases.
    Boitard C
    Immunol Ser; 1993; 59():279-93. PubMed ID: 8461393
    [No Abstract]   [Full Text] [Related]  

  • 15. CD4 antibody therapy in chronic inflammatory dermatological diseases.
    Morel P; Revillard JP; Nicolas JF; Wijdenes J
    Immunol Ser; 1993; 59():271-6. PubMed ID: 8461392
    [No Abstract]   [Full Text] [Related]  

  • 16. Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy.
    Silverman GJ; Weisman S
    Arthritis Rheum; 2003 Jun; 48(6):1484-92. PubMed ID: 12794814
    [No Abstract]   [Full Text] [Related]  

  • 17. CD20: a target antigen for immunotherapy of autoimmune diseases.
    Perosa F; Favoino E; Caragnano MA; Prete M; Dammacco F
    Autoimmun Rev; 2005 Nov; 4(8):526-31. PubMed ID: 16214090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Construction and clinical application of chimeric antibodies].
    Kuroki M; Arakawa F; Haruno M
    Nihon Rinsho; 1995 Dec; 53(12):3122-31. PubMed ID: 8577069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Monoclonal antibodies for treating autoimmune diseases].
    Takeno M; Sakane T
    Nihon Rinsho; 1997 Jun; 55(6):1543-8. PubMed ID: 9200946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deal watch: Boosting TRegs to target autoimmune disease.
    Nat Rev Drug Discov; 2011 Aug; 10(8):566. PubMed ID: 21804584
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.